Synthetic peptide corresponding to Human Parkin aa 298-313.
Our Abpromise guarantee covers the use of ab5667 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use a concentration of 0.5 µg/ml. Detects a band of approximately 52 kDa.Can be blocked with Parkin peptide (ab5865).|
|IHC-Fr||Use a concentration of 1 µg/ml.|
|IP||Use at an assay dependent concentration.|
ab5667 has not yet been referenced specifically in any publications.